LORAZEPAM 0.5 MG TABLET
For 30 tablets
Pharmacies pay
$1.03 filed
30 × $0.03443 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$6.18 estimated
$1.03 + $0.15 (15%) + $5.00 fee per fill = $6.18
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
LORAZEPAM 0.5 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as lorazepam.
FDA gives its dosage form as tablet and its route as oral.
FDA lists 8 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Aurolife Pharma LLC and American Health Packaging.
FDA’s Established Pharmacologic Class for it is Benzodiazepine.
The NADAC file of 2026-10-14 prices it under 17 NDCs (National Drug Codes); the FDA directory lists 16 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $1.03 for 30 tablets (30 × $0.03443 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 8 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Leading Pharma, LLC | 3 | $0.03443 per EA filed |
| SUN PHARMACEUTICAL INDUSTRIES INC | 3 | $0.03443 per EA filed |
| Teva Pharmaceuticals USA, Inc. | 3 | $0.03443 per EA filed |
| Aurolife Pharma LLC | 2 | $0.03443 per EA filed |
| Rising Pharma Holdings, Inc. | 2 | $0.03443 per EA filed |
| ANI Pharmaceuticals, Inc. | 1 | $0.03443 per EA filed |
| American Health Packaging | 1 | $0.03443 per EA filed |
| Chartwell RX, LLC | 1 | $0.03443 per EA filed |
| Not listed as a package in the FDA directory | 1 | $0.03443 per EA filed |
All 17 NDCs, with labeler and price
- 00093-3425-01 · Teva Pharmaceuticals USA, Inc. · $0.03443 per EA · eff. 2026-09-23 filed
- 00093-3425-05 · Teva Pharmaceuticals USA, Inc. · $0.03443 per EA · eff. 2026-09-23 filed
- 00093-3425-10 · Teva Pharmaceuticals USA, Inc. · $0.03443 per EA · eff. 2026-09-23 filed
- 13107-0083-01 · Aurolife Pharma LLC · $0.03443 per EA · eff. 2026-09-23 filed
- 13107-0083-05 · Aurolife Pharma LLC · $0.03443 per EA · eff. 2026-09-23 filed
- 60687-0820-01 · American Health Packaging · $0.03443 per EA · eff. 2026-09-23 filed
- 60687-0820-11 · not listed as a package in the FDA directory · $0.03443 per EA · eff. 2026-09-23 filed
- 62135-0861-01 · Chartwell RX, LLC · $0.03443 per EA · eff. 2026-09-23 filed
- 62559-0195-05 · ANI Pharmaceuticals, Inc. · $0.03443 per EA · eff. 2026-09-23 filed
- 63304-0772-01 · SUN PHARMACEUTICAL INDUSTRIES INC · $0.03443 per EA · eff. 2026-09-23 filed
- 63304-0772-05 · SUN PHARMACEUTICAL INDUSTRIES INC · $0.03443 per EA · eff. 2026-09-23 filed
- 63304-0772-10 · SUN PHARMACEUTICAL INDUSTRIES INC · $0.03443 per EA · eff. 2026-09-23 filed
- 64980-0627-01 · Rising Pharma Holdings, Inc. · $0.03443 per EA · eff. 2026-09-23 filed
- 64980-0627-50 · Rising Pharma Holdings, Inc. · $0.03443 per EA · eff. 2026-09-23 filed
- 69315-0904-01 · Leading Pharma, LLC · $0.03443 per EA · eff. 2026-09-23 filed
- 69315-0904-05 · Leading Pharma, LLC · $0.03443 per EA · eff. 2026-09-23 filed
- 69315-0904-10 · Leading Pharma, LLC · $0.03443 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
9 other products in the NADAC file share the FDA nonproprietary name lorazepam with LORAZEPAM 0.5 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| LORAZEPAM 0.5 MG TABLET this page | $0.03443 per EA filed | We don’t know yet |
| LORAZEPAM 1 MG TABLET | $0.03671 per EA filed | We don’t know yet |
| LORAZEPAM 2 MG TABLET | $0.07314 per EA filed | We don’t know yet |
| LORAZEPAM 2 MG/ML ORAL CONCENT | $0.68632 per ML filed | We don’t know yet |
| LORAZEPAM 2 MG/ML VIAL | $2.17153 per ML filed | $2.197 per ML derived |
| LORAZEPAM INTENSOL 2 MG/ML | $0.68632 per ML filed | We don’t know yet |
| LOREEV XR 1 MG CAPSULE | $14.20977 per EA filed | $14.6965 per EA filed |
| LOREEV XR 1.5 MG CAPSULE | $14.24867 per EA filed | $14.6965 per EA filed |
| LOREEV XR 2 MG CAPSULE | $14.19082 per EA filed | $14.6965 per EA filed |
| LOREEV XR 3 MG CAPSULE | $14.22681 per EA filed | $14.6965 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)
Compared with its class
The middle of its 17 NDCs’ NADAC prices is $0.03443 per EA filed.
Of the 76 other products in FDA’s Benzodiazepine class priced per EA, 68 have a higher middle NADAC price and 8 a lower one. The one in the middle is CLONAZEPAM 1 MG ODT, at $0.56689 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Related pages
Its pharmacologic class
Related in the same class
- ALPRAZOLAM 0.25 MG TABLET
- CLONAZEPAM 0.5 MG TABLET
- DIAZEPAM 10 MG TABLET
- TEMAZEPAM 15 MG CAPSULE
- CLORAZEPATE 15 MG TABLET